Entellus Medical (ENTL) Says 18 and 24-Month Data Confirms Durable Relief of Nasal Obstruction Symptoms with Latera from Spirox
Tweet Send to a Friend
Entellus Medical, Inc. (NASDAQ: ENTL) today announced data from its first-in-human study of the Latera® absorbable nasal implant from Spirox® ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
